Nano-X Imaging Ltd. — Form 6-K Summary
Business context and reporting period
For September 2026, Nano-X Imaging Ltd. reported that it held its adjourned Annual General Meeting on September 29, 2026, at its offices in Petach Tikva, Israel.
Meeting outcomes and material changes
- Shareholders approved by the required majority each proposal described in the company’s August 18, 2026 proxy statement, except Proposal No. 3, which the company had withdrawn under a September 17, 2026 proxy supplement.
- As part of the approved proposals, shareholders amended and restated the company’s Articles of Association. The amended and restated articles were filed as Exhibit 99.1.
- Exhibit 99.1 was incorporated by reference into the company’s Form F-3 and Form S-8 registration statements, subject to documents or reports subsequently filed or furnished.
Financial information and outlook
This 6-K reports shareholder-meeting results and does not provide revenue, profit, cash flow, margins, debt, liquidity, financial guidance, or operating outlook. It also does not describe financial contingencies or unusual financial items.
Key facts for investors to verify
- Review the amended and restated Articles of Association filed as Exhibit 99.1 for the specific governance changes.
- Consult the August 18 proxy statement and September 17 supplement for the proposals approved and the details of withdrawn Proposal No. 3.
- Check subsequent SEC filings for any further amendments or disclosures affecting the articles or incorporated registration statements.